Rakuten Investment Management Inc. Takes $1.07 Million Position in Solventum Corporation $SOLV

Rakuten Investment Management Inc. acquired a new stake in Solventum Corporation (NYSE:SOLV) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 14,600 shares of the company’s stock, valued at approximately $1,066,000.

Other hedge funds also recently bought and sold shares of the company. United Services Automobile Association purchased a new stake in Solventum in the 1st quarter worth approximately $239,000. Woodline Partners LP raised its position in shares of Solventum by 40.7% in the first quarter. Woodline Partners LP now owns 11,677 shares of the company’s stock worth $888,000 after buying an additional 3,377 shares in the last quarter. Intech Investment Management LLC raised its position in shares of Solventum by 167.0% in the first quarter. Intech Investment Management LLC now owns 16,669 shares of the company’s stock worth $1,268,000 after buying an additional 10,425 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in Solventum by 35.5% during the second quarter. Farther Finance Advisors LLC now owns 2,468 shares of the company’s stock valued at $187,000 after buying an additional 647 shares during the period. Finally, Public Employees Retirement System of Ohio grew its position in Solventum by 0.9% during the second quarter. Public Employees Retirement System of Ohio now owns 63,719 shares of the company’s stock worth $4,832,000 after buying an additional 583 shares in the last quarter.

Solventum Trading Down 1.7%

SOLV stock opened at $78.91 on Friday. The company has a market capitalization of $13.69 billion, a PE ratio of 9.09, a price-to-earnings-growth ratio of 7.22 and a beta of 0.34. The company has a debt-to-equity ratio of 1.03, a quick ratio of 1.14 and a current ratio of 1.50. Solventum Corporation has a one year low of $60.70 and a one year high of $88.20. The company’s 50 day moving average price is $81.65 and its two-hundred day moving average price is $75.71.

Solventum (NYSE:SOLV) last announced its quarterly earnings data on Thursday, November 6th. The company reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.43 by $0.07. The company had revenue of $2.10 billion during the quarter, compared to analysts’ expectations of $2.05 billion. Solventum had a net margin of 18.13% and a return on equity of 28.01%. The firm’s revenue was up .7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.64 EPS. Solventum has set its FY 2025 guidance at 5.980-6.080 EPS. As a group, analysts predict that Solventum Corporation will post 6.58 earnings per share for the current fiscal year.

Solventum declared that its board has approved a stock buyback program on Thursday, November 20th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the company to buy up to 7.5% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s management believes its shares are undervalued.

Analysts Set New Price Targets

SOLV has been the subject of a number of research analyst reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Solventum in a research report on Thursday, October 30th. BTIG Research raised shares of Solventum from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research note on Tuesday, December 2nd. Stifel Nicolaus boosted their price target on shares of Solventum from $88.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, January 7th. Piper Sandler reissued an “overweight” rating on shares of Solventum in a report on Wednesday, December 17th. Finally, UBS Group reaffirmed a “neutral” rating on shares of Solventum in a report on Friday, November 21st. Six analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Solventum presently has an average rating of “Hold” and an average price target of $90.27.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.